Comparing PCSK9 inhibitor prescription rates within high-risk populations: diabetes mellitus, multi-territory vascular disease, multivessel and recurrent coronary artery disease
30 August 2024 (11:33 - 11:45)
Organised by: 
About the speaker
The Alfred Hospital, Melbourne (Australia)
4 More presentations in this session
Professor Y. Lu (Shanghai, CN)
Ms I. Engebretsen (Oslo, NO)
Access the full session
The Event
ESC Congress 2024
30 August 2024
11:33 CET
You may be interested in
Congress Session
Congress Session
Congress Session
